Vimta Labs completes sale of its diagnostic and pathological services business
Vimta Labs has completed the sale and transfer of its diagnostic and pathological services business as a going concern to Thyrocare Technologies on 11 October 2024.
Biggest Winners and Losers in MSCI: Key Movers in Global Indices 2025
3 mins read . Aug 20, 2025
What MF Big Boys Bought and Sold – Top Mutual Fund Stock Activity in 2025
8 mins read . Aug 18, 2025
10 Financial Planning Checklist For 2025
7 mins read . Aug 12, 2025
Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account
Recent Article
- •
- •
- •
- •
